Caracterización multiómica del cáncer de mama en mujeres jóvenes: impacto de la lactancia y el embarazo en su mal pronóstico.

Resumen del proyecto

YWBC, defined by patient age up to 45 years, have a 10-30% increased risk of developing breast cancer during the first decade after childbirth compared to nulliparous women, and the risk increases with age. Moreover, the prognosis of breast cancer diagnosed postpartum (PPBC) worsens even after normalization for all clinicopathological factors. Up to 50% of YWBC are diagnosed in parous women during that 10-year window. Studies in rodent models point to lactation and involution of the mammary gland as the main prometastatic drivers of this tumor type. However, the absence of studies in BC cases from women with breastfeeding data makes it unclear whether this theory holds true for humans. Therefore, additional efforts are required to characterize PPBC molecularly, identify its vulnerabilities, improve patient stratification, detect new therapeutic possibilities, and establish efficient methods for early detection to improve the life expectancy of these women in a critical point of their lives, motherhood. Now, we propose to perform an in-depth molecular analysis to understand the tumor cell imprinting and immune tolerance that may promote metastasis in the postpartum period. Our project will use state-of-the-art technologies such as digital spatial tumor microenvironment study, high quality transcriptomic analysis from FFPE samples, and exploring epigenomic signatures governing long-lasting transcriptional changes. All of these will be performed in the largest cohort of YWBC FFPE samples, classified according to the time from childbirth and including data on breastfeeding and weaning. In parallel, we discovered for the first time that early detection of BC can be made through ctDNA in breast milk with exquisite sensitivity, even before the tumor is detected by imaging. And now we plant to explore the utility of the abundant cfRNA present in the milk fat layer as a surrogate of the tumor tissue for molecular subtyping of the disease.

Palabras clave

Cáncer de mama
embarazo
lactancia
transcriptoma
microambiente tumoral
epigenoma

Convocatoria

Acción Estratégica en Salud (AES)

Periodo de ejecución

01/01/2024 - 31/12/2026

Investigador Principal

MIRIAM SANSO MARTINEZ

Centro beneficiario

FUNDACION INSTITUTO DE INVESTIGACION SANITARIA ILLES BALEARS

Centro de realización

INSTITUTO DE INVESTIGACION SANITARIA ILLES BALEARS (IdISBa)

Comunidad Autónoma

BALEARES

Provincia

BALEARS, ILLES

Financiación

242,000 €